BlackRock, Inc. 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
22,865,948 7.700% |
-1,776,718 (-7.21%) |
Filing |
| 2024-01-24 5:23 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
24,642,666 9.200% |
6,108,207 (+32.96%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
18,534,459 8.200% |
1,965,215 (+11.86%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
16,569,244 7.500% |
1,453,754 (+9.62%) |
Filing |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
15,115,490 8.100% |
3,082,170 (+25.61%) |
Filing |